Risk of keratinocyte carcinoma among patients with hidradenitis suppurativa

Br J Dermatol. 2020 Nov;183(5):962-964. doi: 10.1111/bjd.19256. Epub 2020 Jul 9.

Authors

S Ashrafzadeh^{1

2}, Y Kim^{1

2}, G A Peters¹, H Lee³, M M Asgari^{1

2}

Affiliations

¹ Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.
² Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Healthcare Institute, Boston, MA, USA.
³ Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Carcinoma, Squamous Cell* / epidemiology
Carcinoma, Squamous Cell* / etiology
Hidradenitis Suppurativa* / complications
Hidradenitis Suppurativa* / epidemiology
Humans
Keratinocytes

Grants and funding